環泰 is a listed company. Filings by its managers are published through TWSE / TPEx (MOPS). The last twelve months, up to 18 October 2026, brought 4 filings signed by 3 insiders.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
For context, the typical company on the same exchange (median of 518 companies) published 2 filings over the same period, against 4 filings here.
There has been no open-market purchase by an insider of 環泰 for at least a year. Publication is fast: at least half of the trades appear on TWSE / TPEx (MOPS) on the same day. That lag is the time during which only the insider knows about the trade.
Source: insider filings from TWSE / TPEx (MOPS). Past trades are no guide to future returns.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
4 of 4 declarations
環泰 is a company listed on the XTAI market, specializing in the financial sector.
Insider filings
Over the last 90 days, 2 filings published on 15 October 2026: no open-market purchase or sale filed by an insider. 2 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 16 October 2026 (UTC)